QualityStocksNewsBreaks – Vivos Therapeutics Inc.’s Novel Vivos System Could Provide Non-Surgical OSA Relief
Vivos Therapeutics, an emerging global leader in the treatment of obstructive sleep apnea (“OSA”), has developed a proprietary system that holds the potential to relieve OSA symptoms in 18-24 months. A recent article further discussing the company reads, “Vivos created and patented its novel system to combat OSA caused by deficiencies and other tissue anomalies in craniofacial anatomy development, the main cause of 98% of OSA cases. The multidisciplinary treatment protocol is comprised of comfortable and customized oral devices as well as biofunctional therapies, such as training the tongue. Over the course of treatment, the patient’s upper airway is effectively…